Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and I…
This prospective, multinational, multicenter observational study follows patients with non-foveal, non-vision compromising atrophic age‑related macular degeneration for 24 months with 6‑month intervals. It aims to assess individual progression rates, identify focal and global retinal alterations, and evaluate monitoring using approved AI algorithms through routine imaging (Scanning Laser Fundus Photography, Color Fundus Photography, OCT, OCTA). No intervention is performed during the study, though treatment may be provided if approved in the EU.
This prospective, multinational, multicenter observational study follows patients with non-foveal, non-vision compromising atrophic age‑related macular degeneration for 24 months with 6‑month intervals. It aims to assess individual progression rates, identify focal and global retinal alterations, and evaluate monitoring using approved AI algorithms through routine imaging (Scanning Laser Fundus Photography, Color Fundus Photography, OCT, OCTA). No intervention is performed during the study, though treatment may be provided if approved in the EU.
The study provides data for evaluating AI‑based monitoring tools, offering Swiss AI researchers opportunities to contribute to algorithm validation and cross‑border data collaboration in AMD care.
Original source record. Open the original record to verify the underlying announcement.